Method for treatment of acne and/or the effects of ageing using HMG-coenzyme A-reductase inhibitor and compositions for performing the same
AssigneeL'oreal
InventorsLionel Breton, Olivier De Lacharriere
Life of this patent
Estimating the term…
Abstract
A method for the treatment of acne and/or the effects of ageing, by administering, to a subject in need thereof, a composition containing an effective amount of at least one HMG-Coenzyme A-reductase inhibitor in a carrier that is selected from the group consisting of dermatologically acceptable carriers, cosmetically acceptable carriers, and mixtures thereof, and the compositions for performing the method are provided.
Claims18
A method for the treatment of skin ageing by desquamation of skin cells, comprising desquamating skin cells by administrating, to a subject in need thereof, a composition comprising an effective amount of at least one HMG-Coenzyme A-reductase inhibitor and at least one additional active desquamation agent selected from the group consisting of C.sub.8 -alkanoyl salicylic acids in a carrier that is selected from the group consisting of dermatologically acceptable carriers, cosmetically acceptable carriers and mixtures thereof.
A cosmetic composition, comprising at least one HMG-Coenzyme A-reductase inhibitor and at least one additional active desquamation agent selected from the group consisting of C.sub.8 -alkanoyl salicylic acids in a cosmetically acceptable carrier.
A method for the treatment of acne by desquamation of skin cells, comprising desquamating skin cells by administering to a subject in need thereof, a composition comprising an effective amount of at least one HMG-Coenzyme A-reductase inhibitor and at least one additional active desquamating agent selected from the group consisting of C.sub.8 -alkanoyl salicylic acids, in a carrier that is selected from the group consisting of dermatologically acceptable carriers, cosmetically acceptable carriers and mixtures thereof.
Dependencies are inferred from the claim text.